Literature DB >> 2985559

Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.

W B Im, J C Sih, D P Blakeman, J P McGrath.   

Abstract

Omeprazole (5-methoxy-2-[[(4-methoxy-3,5- dimethylpyridinyl)methyl]sulfinyl]-1H-benzimidazole) appeared to inhibit gastric (H+-K+)-ATPase by oxidizing its essential sulfhydryl groups, since the gastric ATPase inactivated by the drug in vivo or in vitro recovered its K+-dependent ATP hydrolyzing activity upon incubation with mercaptoethanol. Biological reducing agents like cysteine or glutathione, however, were unable to reverse the inhibitory effect of omeprazole. Moreover, acidic environments enhanced the potency of omeprazole. For example, in vivo pretreatment of rats with carbachol, a secretagogue, enhanced the activity of omeprazole to inhibit gastric (H+-K+)-ATPase, while pretreatment with cimetidine, an antisecretory agent, reduced its potency. In vitro, lowering pH of incubation media from 7.4 to 5.0 improved the ability of omeprazole to inhibit hog gastric (H+-K+)-ATPase almost 60-fold. The inhibitory effect of the drug was accompanied by a dose-dependently decreased amount of free sulfhydryl groups in the isolated hog gastric membranes. The chemical reactivity of omeprazole with mercaptans is also consistent with the biological action of omeprazole. The drug, only under acidic conditions, reacted with a stoichiometric amount of ethyl mercaptan (or beta-mercaptoethanol) to produce regio-isomers of N-sulfenylated omeprazole sulfide (5-methoxy-2[[(4-methoxy-3,5- dimethyl-2-pyridinyl)methyl]thio]-1- or 3-(ethylthio)benzimidazole). The N-sulfenylated compound reacted at neutral pH with another stoichiometric amount of ethyl mercaptan to produce omeprazole sulfide quantitatively. The gastric polypeptides of 100 kilodaltons representing (H+-K+)-ATPase in the rat gastric mucosa or isolated hog gastric membranes were covalently labeled with [14C]omeprazole. The radioactive label bound to the ATPase, however, could not be displaced by mercaptoethanol under the identical conditions where the ATPase activity was fully restored. These observations suggest that the essential sulfhydryl groups which reacted with omeprazole did not form a stable covalent bond with the drug, but rather that they further reacted with adjacent sulfhydryl groups to form disulfides which could be reduced by mercaptoethanol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985559

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

2.  Demonstration of the electrogenicity of proton translocation during the phosphorylation step in gastric H+K(+)-ATPase.

Authors:  H T van der Hijden; E Grell; J J de Pont; E Bamberg
Journal:  J Membr Biol       Date:  1990-04       Impact factor: 1.843

3.  Ouabain-insensitive K-adenosine triphosphatase in distal nephron segments of the rabbit.

Authors:  L C Garg; N Narang
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

4.  The effect of omeprazole on ultrastructural changes in gastric parietal cells.

Authors:  H Karasawa; N Tani; T Miwa
Journal:  Gastroenterol Jpn       Date:  1988-02

5.  Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro.

Authors:  J Tuukkanen; H K Väänänen
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

6.  Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.

Authors:  M A Mohiuddin; K G Pursnani; D A Katzka; R M Gideon; J A Castell; D O Castell
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

7.  Antileishmanial activity of the antiulcer agent omeprazole.

Authors:  Suping Jiang; Juliana Meadows; Steven A Anderson; Antony J Mukkada
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 8.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

9.  Effect of omeprazole on eicosanoid formation in and release from guinea-pig gastric mucosal cells.

Authors:  M Hell; K F Sewing
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

10.  Synthesis of benzo[d]thiazole-hydrazone analogues: molecular docking and SAR studies of potential H+/K+ ATPase inhibitors and anti-inflammatory agents.

Authors:  Shi-Meng Wang; Gao-Feng Zha; K P Rakesh; N Darshini; T Shubhavathi; H K Vivek; N Mallesha; Hua-Li Qin
Journal:  Medchemcomm       Date:  2017-04-26       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.